[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (520)

Search Parameters:
Keywords = PCP

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
23 pages, 1060 KiB  
Review
Distribution, Biosynthesis, and Function of Carotenoids in Oxygenic Phototrophic Algae
by Shinichi Takaichi
Mar. Drugs 2025, 23(2), 62; https://doi.org/10.3390/md23020062 - 31 Jan 2025
Viewed by 236
Abstract
For photosynthesis, oxygenic phototrophic organisms necessarily contain not only chlorophylls but also carotenoids. Various carotenoids have been identified in algae and taxonomic studies of algae have been conducted. In this review, the relationship between the distribution of chlorophylls and carotenoids and the phylogeny [...] Read more.
For photosynthesis, oxygenic phototrophic organisms necessarily contain not only chlorophylls but also carotenoids. Various carotenoids have been identified in algae and taxonomic studies of algae have been conducted. In this review, the relationship between the distribution of chlorophylls and carotenoids and the phylogeny of sea and freshwater oxygenic phototrophs, including cyanobacteria, red algae, brown algae, and green algae, is summarized. These phototrophs contain division- or class-specific chlorophylls and carotenoids, such as fucoxanthin, peridinin, diadinoxanthin, and siphonaxanthin. The distribution of β-carotene and its derivatives, including β-carotene, zeaxanthin, violaxanthin, neoxanthin, diadinoxanthin, fucoxanthin, and peridinin (β-branch carotenoids), are limited to divisions of a part of Rhodophyta, Cryptophyta, Heterokontophyta, Haptophyta, and Dinophyta. Meanwhile, the distribution of α-carotene and its derivatives, such as lutein, loroxanthin, and siphonaxanthin (α-branch carotenoids), are limited to divisions of a part of Rhodophyta (macrophytic type), Cryptophyta, Euglenophyta, Chlorarachniophyta, and Chlorophyta. In addition, carotenogenesis pathways are also discussed based on the chemical structures of carotenoids and the known characteristics of carotenogenesis enzymes in other organisms. The specific genes and enzymes for carotenogenesis in algae are not yet known. Most carotenoids bind to membrane-bound pigment-protein complexes, such as reaction centers and light-harvesting complexes. Some carotenoids function in photosynthesis and are briefly summarized. Water-soluble peridinin-chlorophyll a-protein (PCP) and orange carotenoid protein (OCP) have also been characterized. This review is a summary and update from the previous review on the distribution of major carotenoids, primary carotenogenesis pathways, and the characteristics of carotenogenesis enzymes and genes. Full article
(This article belongs to the Special Issue Recent Advances in Marine-Derived Pigments)
18 pages, 2368 KiB  
Article
Hydrogen Production from Chemical Hydrides via Porous Carbon Particle Composite Catalyst Embedding of Metal Nanoparticles
by Sahin Demirci, Osman Polat and Nurettin Sahiner
Micromachines 2025, 16(2), 172; https://doi.org/10.3390/mi16020172 - 31 Jan 2025
Viewed by 234
Abstract
Porous carbon particles (PCPs) prepared from sucrose via the hydrothermal method and its modified forms with polyethyleneimine (PEI) as PCP-PEI were used as templates as in situ metal nanoparticles as M@PCP and M@PCP-PEI (M:Co, Ni, or Cu), respectively. The prepared M@PCP and M@PCP-PEI [...] Read more.
Porous carbon particles (PCPs) prepared from sucrose via the hydrothermal method and its modified forms with polyethyleneimine (PEI) as PCP-PEI were used as templates as in situ metal nanoparticles as M@PCP and M@PCP-PEI (M:Co, Ni, or Cu), respectively. The prepared M@PCP and M@PCP-PEI composites were used as catalysts in the hydrolysis of NaBH4 and NH3BH3 to produce hydrogen (H2). The amount of Co nanoparticles within the Co@PCP-PEI structure was steadily increased via multiple loading/reducing cycles, e.g., from 29.8 ± 1.1 mg/g at the first loading/reducing cycles to 44.3 ± 4.9 mg/g after the third loading/reducing cycles. The Co@PCP-PEI catalyzed the hydrolysis of NaBH4 within 120 min with 251 ± 1 mL H2 production and a 100% conversion ratio with a 3.8 ± 0.3 mol H2/(mmol cat·min) turn-over frequency (TOF) and a lower activation energy (Ea), 29.3 kJ/mol. In addition, the Co@PCP-PEI-catalyzed hydrolysis of NH3BH3 was completed in 28 min with 181 ± 1 mL H2 production at 100% conversion with a 4.8 ± 0.3 mol H2/(mmol cat·min) TOF value and an Ea value of 32.5 kJ/mol. Moreover, Co@PCP-PEI composite catalysts were afforded 100% activity up to 7 and 5 consecutive uses in NaBH4 and NH3B3 hydrolysis reactions, respectively, with all displaying 100% conversions for both hydrolysis reactions in the 10 successive uses of the catalyst. Full article
(This article belongs to the Section C:Chemistry)
Show Figures

Figure 1

Figure 1
<p>Schematic presentation of Co, Ni, or Cu metal nanoparticle synthesis within PCP and PCP-PEI structures.</p>
Full article ">Figure 2
<p>The catalytic activity of (<b>a</b>) M@PCP and (<b>b</b>) M@PCP-PEI composites on the hydrolysis of NaBH<sub>4</sub> to produce H<sub>2</sub>; comparison of (<b>c</b>) TOF and (<b>d</b>) HGR values of M@PCP and M@PCP-PEI composite-catalyzed NaBH<sub>4</sub> hydrolysis reactions, and (<b>e</b>) TEM images of M@PCP-PEI composites [reaction conditions: M:Co, Ni, or Cu, 0.0476 mmol M for M@PCP, 0.0788 mmol M for M@PCP-PEI, 50 mL water, 0.0965 g NaBH4, 30 °C, 1000 rpm].</p>
Full article ">Figure 3
<p>(<b>a</b>) The effect of the amount of Co metal nanoparticles on the catalytic activity of Co@PCP-PEI composites in the hydrolysis of NaBH<sub>4</sub>; (<b>b</b>) comparison of TOF and HGR values of multiple-Co(II)-loaded/reduced Co@PCP-PEI composite catalyst; (<b>c</b>) effect of temperature on the hydrolysis of NaBH<sub>4</sub> catalyzed by Co@PCP-PEI composite catalysts (Co: 29.8 ± 1.1 mg/g); (<b>d</b>) comparison of TOF and HGR values of Co@PCP-PEI composite catalysts for the hydrolysis of NaBH<sub>4</sub> carried out at different temperatures (Co: 29.8 ± 1.1 mg/g) [reaction conditions: 50 mL water, 0.0965 g NaBH<sub>4</sub>, mixing rate: 1000 rpm].</p>
Full article ">Figure 4
<p>(<b>a</b>) The catalytic activity of M@PCP-PEI composite catalysts in the hydrolysis of NH<sub>3</sub>BH<sub>3</sub> to produce H<sub>2</sub>, and (<b>b</b>) comparison of TOF and HGR values of the M@PCP-PEI composite catalyst [reaction condition: M:Co, Ni, or Cu, 0.0788 mmol M, 50 mL water, 0.0795 g NH<sub>3</sub>BH<sub>3</sub>, 30 °C, 1000 rpm].</p>
Full article ">Figure 5
<p>(<b>a</b>) The effect of the amounts of Co metal nanoparticles on the catalytic activity of Co@PCP-PEI composites in the hydrolysis of NH<sub>3</sub>BH<sub>3</sub>; (<b>b</b>) comparison of TOF and HGR values; (<b>c</b>) the effect of temperature on the Co@PCP-PEI composite-catalyzed hydrolysis of NH<sub>3</sub>BH<sub>3</sub>; (<b>d</b>) comparison of TOF and HGR values at different temperatures [reaction conditions: 50 mL water, 0.07955 g NH<sub>3</sub>BH<sub>3</sub>, 1000 rpm].</p>
Full article ">Figure 6
<p>The reusability of Co@PCP-PEI composite catalysts in the hydrolysis of (<b>a</b>) NaBH<sub>4</sub> and (<b>b</b>) NH<sub>3</sub>BH<sub>3</sub> [reaction conditions: 0.0788 mmol Co, 50 mL water, 0.0965 g NaBH<sub>4</sub>, 0.0795 g NH<sub>3</sub>BH<sub>3</sub>, 30 °C, 1000 rpm].</p>
Full article ">
22 pages, 1085 KiB  
Article
Adapting and Implementing a Blended Collaborative Care Intervention for Older Adults with Multimorbidity: Quantitative and Qualitative Results from the ESCAPE Pilot Study
by Josefine Schulze, Dagmar Lühmann, Jonas Nagel, Cornelia Regner, Christine Zelenak, Kristina Bersch, Christoph Herrmann-Lingen, Matthew M. Burg and Birgit Herbeck-Belnap
Behav. Sci. 2025, 15(1), 79; https://doi.org/10.3390/bs15010079 - 17 Jan 2025
Viewed by 661
Abstract
Multimorbidity poses significant challenges for patients and healthcare systems, often exacerbated by fragmented care and insufficient collaboration across providers. Blended Collaborative Care (BCC) is a promising strategy to address care complexity by partnering care managers (CMs) with primary care providers (PCPs) and specialists. [...] Read more.
Multimorbidity poses significant challenges for patients and healthcare systems, often exacerbated by fragmented care and insufficient collaboration across providers. Blended Collaborative Care (BCC) is a promising strategy to address care complexity by partnering care managers (CMs) with primary care providers (PCPs) and specialists. This study aimed to adapt and pilot a BCC intervention for patients aged 65+ with heart failure and physical–mental multimorbidity. Our objectives were to assess the feasibility of the study procedures, patient recruitment, participant satisfaction and acceptability, and to identify necessary adjustments for improving intervention delivery. We evaluated goal attainment and intervention fidelity through standardised electronic documentation by CMs, and patient acceptance and satisfaction through semi-structured interviews. A monocentric, one-arm pilot study involved nine patients with a mean of 6.7 contacts with their CM over three months. Patients’ health goals primarily focused on lifestyle changes and psychosocial support. The intervention was generally well-accepted, with no reported negative consequences. Difficulties in establishing working alliances with PCPs were a barrier to effective implementation. The analysis indicated the need for minor procedural adjustments. Next steps include launching the ESCAPE trial, a large randomised-controlled trial across different European healthcare systems and developing strategies to facilitate PCP involvement. Full article
(This article belongs to the Special Issue Providing Emotional Support for People with Chronic Diseases)
Show Figures

Figure 1

Figure 1
<p>Logic model of the ESCAPE BCC intervention.</p>
Full article ">Figure 2
<p>Flowchart of participants’ progress through the phases of the pilot study.</p>
Full article ">
19 pages, 4179 KiB  
Article
Pneumocystis Pneumonia Severity Is Associated with Taxonomic Shifts in the Respiratory Microbiota
by Valentina Del Prete, Antonia Piazzesi, Matteo Scanu, Francesca Toto, Stefania Pane, Federica Berrilli, Giovangiacinto Paterno, Lorenza Putignani and David di Cave
Pathogens 2025, 14(1), 82; https://doi.org/10.3390/pathogens14010082 - 16 Jan 2025
Viewed by 479
Abstract
Pneumonia caused by Pneumocystis jirovecii infection (PCP) is a potentially life-threatening illness, particularly affecting the immunocompromised. The past two decades have shown an increase in PCP incidence; however, the underlying factors that promote disease severity and fatality have yet to be fully elucidated. [...] Read more.
Pneumonia caused by Pneumocystis jirovecii infection (PCP) is a potentially life-threatening illness, particularly affecting the immunocompromised. The past two decades have shown an increase in PCP incidence; however, the underlying factors that promote disease severity and fatality have yet to be fully elucidated. Recent evidence suggests that the microbiota of the respiratory tract may play a role in stimulating or repressing pulmonary inflammation, as well as the progression of both bacterial and viral pneumonia. Here, we employed 16S rRNA metataxonomic sequencing to profile the respiratory microbiota of patients with mild-moderate and severe PCP. Our results show that the upper and lower airways of PCP patients have bacterial profiles which have been associated with a pro-inflammatory response. Furthermore, we find that severe PCP is associated with lower bacterial diversity and an increase in Prevotella and a decrease in Neisseria. Functionally, severe PCP was associated with a decrease in metabolic pathways of molecules with anti-inflammatory and antimicrobial properties. To our knowledge, this is the first study showing an association of PCP severity with shifts in the respiratory microbiome and may provide some insight into which patients are more susceptible to the more severe manifestations of the disease. Full article
Show Figures

Figure 1

Figure 1
<p>Bacterial diversity is similar between upper and lower airways. (<b>A</b>–<b>C</b>) Bacterial alpha diversity measurements in bronchoalveolar lavage (BAL) and sputum (SPT) samples in patients with <span class="html-italic">Pneumocystis</span> pneumonia (PCP), measured by bias-corrected Chao-1 (<b>A</b>), Shannon entropy (<b>B</b>), and Simpson’s index (<b>C</b>) analyses. Statistical analysis: Kruskal–Wallis test. (<b>D</b>–<b>F</b>) Beta-diversity analysis as measured by Bray–Curtis dissimilarity analysis (<b>D</b>), weighted UniFrac (<b>E</b>), and unweighted UniFrac (<b>F</b>) analyses on bacterial populations in BAL and SPT samples from patients with PCP.</p>
Full article ">Figure 2
<p>Metataxonomy of bacterial populations in the upper and lower airways of patients with PCP. (<b>A</b>–<b>E</b>) Pie charts of the most abundant phyla (<b>A</b>), classes (<b>B</b>), order (<b>C</b>), families (<b>D</b>), and genera (<b>E</b>) in BAL and SPT samples in patients with PCP.</p>
Full article ">Figure 3
<p>Differentially abundant bacterial taxa in patients with PCP. (<b>A</b>–<b>D</b>) Bar charts of differentially abundant phyla (<b>A</b>), classes (<b>B</b>), orders (<b>C</b>), and families (<b>D</b>) in BAL samples (green) compared to SPT (orange). All bars represent mean ± S.E.M. (<b>E</b>) Bar chart of the most abundant genera in each patient sample. (<b>F</b>,<b>G</b>) Boxplots of the relative abundances in Corynebacterium (<b>F</b>) and Campylobacter (<b>G</b>) in BAL and SPT samples in patients with PCP. Statistical analysis: negative binomial generalized linear model (GLM) corrected for FDR. * <span class="html-italic">p</span> &lt; 0.05, *** <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">Figure 4
<p>Differentially abundant bacterial species in patients with PCP. (<b>A</b>–<b>I</b>) Boxplots of the relative abundances in <span class="html-italic">Prevotella</span> (<b>A</b>), <span class="html-italic">Prevotella pallens</span> (<b>B</b>), <span class="html-italic">Prevotella tannerae</span> (<b>C</b>), <span class="html-italic">Prevotella nanceiensis</span> (<b>D</b>), <span class="html-italic">Rothia</span> (<b>E</b>), <span class="html-italic">Rothia mucilaginosa</span> (<b>F</b>), <span class="html-italic">Rothia dentocariosa</span> (<b>G</b>), <span class="html-italic">Bulleidia moorei</span> (<b>H</b>), and <span class="html-italic">Capnocytophaga ochracea</span> (<b>I</b>) in BAL and SPT samples in patients with PCP. Statistical analysis: negative binomial generalized linear model (GLM) corrected for FDR, * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01; **** <span class="html-italic">p</span> &lt; 0.0001.</p>
Full article ">Figure 5
<p>Patients with severe PCP have lower bacterial diversity than patients with mild-moderate PCP. (<b>A</b>–<b>C</b>) Bacterial alpha diversity measurements in BAL samples in patients with mild-moderate and severe PCP, measured by bias-corrected Chao-1 (<b>A</b>), Shannon entropy (<b>B</b>), and Simpson’s index (<b>C</b>) analyses. Statistical analysis: Kruskal–Wallis test. (<b>D</b>–<b>F</b>) Beta-diversity analysis as measured by Bray–Curtis dissimilarity analysis (<b>D</b>), weighted UniFrac (<b>E</b>), and unweighted UniFrac (<b>F</b>) analyses on bacterial populations in BAL samples from patients with mild-moderate and severe PCP.</p>
Full article ">Figure 6
<p>Metataxonomy of bacterial populations in the lower airways of patients with PCP. (<b>A</b>,<b>B</b>) Pie chart (<b>A</b>) and bar plot (<b>B</b>) of the most abundant phyla in BAL samples of patients with PCP. (<b>C</b>,<b>D</b>) Pie chart (<b>C</b>) and bar plot (<b>D</b>) of the most abundant classes in BAL samples of patients with PCP. (<b>E</b>,<b>F</b>) Pie chart (<b>E</b>) and bar plot (<b>F</b>) of the most abundant orders in BAL samples of patients with PCP. (<b>G</b>,<b>H</b>) Pie chart (<b>G</b>) and bar plot (<b>H</b>) of the most abundant families in BAL samples of patients with PCP. Statistical analysis: negative binomial generalized linear model (GLM) corrected for FDR. ** <span class="html-italic">p</span> &lt; 0.01; *** <span class="html-italic">p</span> &lt; 0.001; **** <span class="html-italic">p</span> &lt; 0.0001.</p>
Full article ">Figure 7
<p>Metataxonomy of bacterial genera and species in the lower airways of patients with PCP. (<b>A</b>) Pie chart of the most abundant genera in BAL samples of patients with PCP. (<b>B</b>) Stacked bar plot of the most abundant genera in each patient with PCP. Genera under 1% relative abundance were collectively represented as “other”. (<b>C</b>–<b>G</b>) Boxplots of the relative abundances in <span class="html-italic">Prevotella</span> (<b>C</b>), <span class="html-italic">Actinomyces</span> (<b>D</b>), <span class="html-italic">Neisseria</span> (<b>E</b>), <span class="html-italic">Prevotella pallens</span> (<b>F</b>) and <span class="html-italic">Prevotella melaninogenica</span> (<b>G</b>), in BAL samples in patients with mild-moderate and severe PCP. Statistical analysis: negative binomial generalized linear model (GLM) corrected for FDR. * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01; *** <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">Figure 8
<p>Inferred functional profiles of pulmonary bacterial populations in patients with mild-moderate versus severe PCP. Bar chart of microbial metabolic pathways predicted to be differentially regulated in the lower airways of patients with PCP. Each bar represents one metabolic pathway, only statistically significant results with a confidence cutoff of 1 are represented. Blue: pathways predicted to be overrepresented in patients with mild-moderate PCP; red: pathways predicted to be enriched in patients with severe PCP.</p>
Full article ">
32 pages, 9144 KiB  
Article
Small Extracellular Vesicles Promote Axon Outgrowth by Engaging the Wnt-Planar Cell Polarity Pathway
by Samar Ahmad, Tania Christova, Melanie Pye, Masahiro Narimatsu, Siyuan Song, Jeffrey L. Wrana and Liliana Attisano
Cells 2025, 14(1), 56; https://doi.org/10.3390/cells14010056 - 6 Jan 2025
Viewed by 825
Abstract
In neurons, the acquisition of a polarized morphology is achieved upon the outgrowth of a single axon from one of several neurites. Small extracellular vesicles (sEVs), such as exosomes, from diverse sources are known to promote neurite outgrowth and thus may have therapeutic [...] Read more.
In neurons, the acquisition of a polarized morphology is achieved upon the outgrowth of a single axon from one of several neurites. Small extracellular vesicles (sEVs), such as exosomes, from diverse sources are known to promote neurite outgrowth and thus may have therapeutic potential. However, the effect of fibroblast-derived exosomes on axon elongation in neurons of the central nervous system under growth-permissive conditions remains unclear. Here, we show that fibroblast-derived sEVs promote axon outgrowth and a polarized neuronal morphology in mouse primary embryonic cortical neurons. Mechanistically, we demonstrate that the sEV-induced increase in axon outgrowth requires endogenous Wnts and core PCP components including Prickle, Vangl, Frizzled, and Dishevelled. We demonstrate that sEVs are internalized by neurons, colocalize with Wnt7b, and induce relocalization of Vangl2 to the distal axon during axon outgrowth. In contrast, sEVs derived from neurons or astrocytes do not promote axon outgrowth, while sEVs from activated astrocytes inhibit elongation. Thus, our data reveal that fibroblast-derived sEVs promote axon elongation through the Wnt-PCP pathway in a manner that is dependent on endogenous Wnts. Full article
(This article belongs to the Section Cell Signaling)
Show Figures

Figure 1

Figure 1
<p>sEVs promote the growth of the prospective axon. (<b>A</b>) A schematic of the experimental set up. Mouse cortical neurons (E15.5-16.5) are treated with sEVs isolated from fibroblast-conditioned media (CM) using differential centrifugation. (<b>B</b>) Representative immunoblotting of cell lysates and sEV pellets (100,000× <span class="html-italic">g</span>) from the indicated fibroblast cell lines for EV markers CD81, Flotillin1, and TSG101, and the ER protein, calnexin (CNX). (<b>C</b>) Nanoparticle tracking analysis (NTA) of differential centrifugation pellets. A representative plot indicating the particle size distribution from three independent purifications is shown. (<b>D</b>) Representative transmission electron microscopy (TEM) images of sEV-containing pellets. Arrowheads indicate round vesicles. Scale bar, 200 nm. (<b>E</b>–<b>I</b>) Cortical neurons were treated with sEVs (5 μg/mL) purified from the indicated fibroblast cell lines, 4 h after plating. Neurons were fixed at 24 and 33 h, and neuronal morphology was examined after staining for Tuj1. (<b>E</b>) Representative images are shown. Arrowheads mark the longest neurite. Scale bar, 40 μm. (<b>F</b>–<b>I</b>) The length of the longest neurite (prospective axon; <b>F</b>), individual neurite/dendrite lengths (<b>G</b>), total dendrite length (longest neurite excluded; <b>H</b>), and total number of neurites (<b>I</b>) were quantified from a minimum of 90 neurons per condition from three independent experiments. Neurite lengths are plotted as a violin plot with values from each experiment distinctly colored and the median marked by a black line (<b>F</b>,<b>G</b>,<b>H</b>). The number of neurites is plotted as the average of the median ± SEM (<b>I</b>), where each dot represents the median from 30 neurons from one of the three independent experiments. Statistical significance: * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001 using one-way ANOVA with Dunnett’s post-test.</p>
Full article ">Figure 2
<p>sEVs promote the growth of the prospective axon. The PCP components, Pk1/2 and Vangl2, are required for sEV-induced growth of the longest neurite. (<b>A</b>–<b>C</b>,<b>E</b>–<b>G</b>) Pk1/2 and Vangl2 promote sEV-induced neurite outgrowth. Dissociated E15.5-16.5 mouse cortical neurons were electroporated with siRNA against Pk1 (siPk1) and Pk2 (siPk2) (<b>A</b>–<b>C</b>), or Vangl1 (siVangl1) and Vangl2 (siVangl2) (<b>E</b>–<b>G</b>) individually or in combination or with siControl (siCtl) along with a GFP-expressing plasmid and were treated with sEVs (5 μg/mL) from L cells, 4 h after plating. Neurons were fixed at 24 and 33 h, and neuronal morphology was examined in GFP-positive neurons. (<b>A</b>,<b>E</b>) Representative images are shown. Arrowheads mark the longest neurite. Scale bar, 40 μm. (<b>B</b>,<b>F</b>) The length of the longest neurites was quantified. (<b>C</b>,<b>G</b>) Knockdown efficiency for Pk1/Pk2 (<b>C</b>) and Vangl1/2 (<b>G</b>) was determined in GFP-positive neurons isolated by FACS. Relative mRNA expression was determined by qPCR. (<b>D</b>,<b>I</b>) Pk1/2 and Vangl2 promote sEV-induced neurite outgrowth in mutant mouse models. Cortical neurons (E15.5-16.5) were isolated from Pk1 and Pk2 conditional knockout mice obtained by crossing <span class="html-italic">Pk</span> floxed mice with a <span class="html-italic">Nestin-Cre</span> line (<b>D</b>) or <span class="html-italic">Vangl2</span> mutant littermates obtained by crossing heterozygous loop-tail mutants (<span class="html-italic">Vangl2<sup>+/Lp</sup></span>) (<b>I</b>). Neurons were treated with sEVs from L cells, 4 h after plating, fixed at 24 and 33 h, and morphology examined in Tuj1 stained neurons. The length of the longest neurite was quantified from 40 neurons per embryo, and the total number of embryos analyzed is indicated below the genotypes. Violin plots with the median marked by a black line are shown. (<b>H</b>) Loop-tail embryos (E15.5-E16.5) exhibit an open neural tube. Representative images are shown from a minimum of four independent experiments. Arrowheads mark the open neural tube. In siRNA experiments, neurite lengths are quantified from a minimum of 90 neurons per condition from three independent experiments and plotted as a violin plot with values from each experiment distinctly colored and the median marked by a black line (<b>B</b>,<b>F</b>). For qPCR plots, data is presented as the mean ± SEM from 3 independent experiments (<b>C</b>,<b>G</b>). Statistical significance: * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001 using one-way ANOVA with Dunnett’s post-test (<b>C</b>,<b>G</b>), or two-way ANOVA with Tukey’s post-test (<b>B</b>,<b>D</b>,<b>F</b>,<b>I</b>).</p>
Full article ">Figure 3
<p>sEVs promote the growth of the prospective axon. (<b>A</b>–<b>D</b>) Dissociated E15.5-16.5 mouse cortical neurons were treated with sEVs (5 μg/mL) from L cells, 4 h after plating. (<b>A</b>,<b>B</b>) Neurons were co-treated with IgG or an Fzd blocking antibody, F2.A (at 50 nM and 100 nM), along with sEVs. (<b>C</b>,<b>D</b>) Neurons were electroporated with siRNA against Fzds (siFzds) or siControl in combination with a GFP-expressing plasmid prior to the addition of sEVs. Neurons were fixed at 24 and 33 h, and neuronal morphology was examined in Tuj1 stained (<b>A</b>,<b>B</b>) or GFP-positive neurons (<b>C</b>,<b>D</b>), with representative images shown. Arrowheads mark the longest neurite. Scale bar, 40 μm. (<b>B</b>–<b>D</b>) The length of the longest neurite was quantified. Neurite lengths are quantified from a minimum of 90 neurons per condition from three independent experiments and plotted as a violin plot with values from each experiment distinctly colored, and the median marked by a black line (<b>B</b>,<b>D</b>). Statistical significance: *** <span class="html-italic">p</span> &lt; 0.001 using one-way ANOVA with Dunnett’s post-test (<b>B</b>), or two-way ANOVA with Tukey’s post-test (<b>D</b>).</p>
Full article ">Figure 4
<p>sEVs promote the growth of the prospective axon. (<b>A</b>,<b>B</b>) Dissociated E15.5-16.5 mouse cortical neurons were treated with sEVs (5 μg/mL) from L cells, 4 h after plating. Neurons were electroporated with siRNA against Dvls (siDvl) or siControl in combination with a GFP-expressing plasmid prior to the addition of sEVs. Neurons were fixed at 24 and 33 h, and neuronal morphology was examined in GFP-positive neurons, with representative images shown (<b>A</b>). Arrowheads mark the longest neurite. Scale bar, 40 μm. (<b>B</b>) The length of the longest neurite was quantified. (<b>C</b>,<b>D</b>) sEVs promote localization of Vangl2 to the distal axon. Cortical neurons were treated with sEVs from L cells, 4 h after plating and fixed after 24 h. Representative confocal images of neurons stained with DAPI (blue), Vangl2 (green), and Tuj1 (red) are shown. Arrowheads mark the Vangl2 localization. Scale bar, 50 μm. (<b>D</b>) The ratio of distal/proximal Vangl2 intensity and the relative intensity of Vangl2 in the soma is quantified from 30 neurons from three independent experiments. Neurite lengths are quantified from a minimum of 90 neurons per condition from three independent experiments and plotted as a violin plot with values from each experiment distinctly colored, and the median marked by a black line (<b>B</b>). For Vangl2 plots, data are presented as the mean ± SEM from 3 independent experiments (<b>D</b>). Statistical significance: ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001 using unpaired <span class="html-italic">t</span>-test (<b>D</b>), or two-way ANOVA with Tukey’s post-test (<b>B</b>).</p>
Full article ">Figure 5
<p>Neuronal Wnts mediate sEV-induced growth of the longest neurite. (<b>A</b>,<b>E</b>) Schematics illustrating the experimental setup. (<b>A</b>–<b>G</b>) Dissociated E15.5-16.5 mouse cortical neurons were treated with sEVs isolated from L cells transfected with siCtl or siPorcupine (<b>A</b>–<b>D</b>) or with sEVs isolated from regular L cells (<b>E</b>–<b>G</b>). Neurons were treated with PBS as a control and with Porcupine (Porcn) inhibitors, IWP2 (10 μM) or LGK974 (1 and 5 μM) (<b>E</b>–<b>G</b>), 4 h after plating and co-incubated with sEVs. (<b>H</b>–<b>L</b>) Cortical neurons were electroporated with siRNAs against Wls (siWls) (<b>H</b>,<b>I</b>) or Wnts (siWnts) (<b>K</b>,<b>L</b>) or siControl (siCtl) along with a GFP-expressing plasmid and then treated with sEVs (5 μg/mL) from L cells, 4 h after plating. Neurons were fixed at 24 and 33 h, and neuronal morphology was examined in Tuj1 stained neurons (<b>B</b>,<b>C</b>,<b>F</b>,<b>G</b>) or GFP-positive neurons for siRNA experiments (<b>H</b>,<b>I</b>,<b>K</b>,<b>L</b>). Representative images (<b>B</b>,<b>F</b>,<b>H</b>,<b>K</b>) and quantifications of the longest neurite (<b>C</b>,<b>G</b>,<b>I</b>,<b>L</b>) are shown. Arrowheads mark the longest neurite. Scale bar, 40 μm. (<b>D</b>,<b>J</b>) Knockdown efficiency for Porcupine (<b>D</b>) and Wls (<b>J</b>) was determined in L cells and GFP-positive neurons isolated by FACS, respectively. Relative mRNA expression was determined by qPCR. Neurite lengths are quantified from a minimum of 90 neurons per condition from three independent experiments and plotted as a violin plot with values from each experiment distinctly colored and the median marked by a black line (<b>C</b>,<b>G</b>,<b>I</b>,<b>L</b>). For all other plots, data is presented as the mean ± SEM from three independent experiments (<b>D</b>,<b>J</b>). Statistical significance: *** <span class="html-italic">p</span> &lt; 0.001 using unpaired <span class="html-italic">t</span>-test (<b>D</b>,<b>J</b>), one-way ANOVA with Dunnett’s post-test (<b>C</b>,<b>G</b>), or two-way ANOVA with Tukey’s post-test (<b>I</b>,<b>L</b>).</p>
Full article ">Figure 6
<p>sEVs promote neurite elongation and can colocalize with Wnt7b. (<b>A</b>–<b>C</b>) sEVs promote neurite elongation. (<b>A</b>) A schematic illustration of the two-compartment Xona microfluidic device. The somal compartment is connected to the axonal compartment through a 150 μm microgroove. (<b>B</b>) Cortical neurons (E15.5-16.5) were seeded in the somal compartment and cultured for 5 days prior to the addition of L cell-derived sEVs in either the somal or axonal compartment. Neurons were fixed 24 h later, and neuronal morphology was examined in Tuj1 stained neurons. Representative images are shown. Scale bar, 200 μm. (<b>C</b>) The length of the neurites growing in the microgroove and emerging in the axonal compartment was quantified for a minimum of 90 neurites. A dotted line marks both ends of the microgroove (150 μm). (<b>D</b>–<b>I</b>) sEVs can be internalized by neurons and colocalize with Wnts. Cortical neurons were treated with 10X concentrated conditioned media (CM) from L cells stably expressing CD81-EYFP, 4 h after plating for 29 h (<b>F</b>) or 24 h after plating for 30 min (<b>G</b>–<b>I</b>). In panel (<b>G</b>), after 30 min of treatment, neurons were washed and subsequently treated with regular complete media for 0, 2, 4, and 24 h. Representative images of neurons immunostained with GFP and Tuj1 (<b>F</b>,<b>G</b>) or GFP, Tuj1, and Wnt7b (<b>H</b>) are shown. Dashed boxes (<b>H</b>) indicate higher magnification of neurons. Arrowheads mark GFP puncta of internalized sEVs. Scale bar, 20 μm (<b>F</b>) or 40 μm (<b>G</b>,<b>H</b>). (<b>E</b>) Characterization of sEVs. The concentrated CM (10X) and sEV pellet from L cells were immunoblotted with anti-GFP antibody. (<b>I</b>) Pearson’s colocalization coefficient for (<b>H</b>). Neurons were identified using Tuj1 as a reference channel, and the colocalization coefficient was quantified using Nikon NIS-Elements software. Images (<b>F</b>,<b>G</b>,<b>H</b>) and the quantification (<b>I</b>) are representative of 30 neurons from 3 independent experiments. In all the violin plots, values are distinctly colored for each experiment, and the median is marked by a black line. Statistical significance: *** <span class="html-italic">p</span> &lt; 0.001 using unpaired <span class="html-italic">t</span>-test (<b>I</b>) or one-way ANOVA with Dunnett’s post-test (<b>C</b>).</p>
Full article ">Figure 7
<p>sEVs from neurons and astrocytes do not promote the growth of the longest neurite. (<b>A</b>) A schematic illustration of the experimental set up. Dissociated E15.5-16.5 cortical neurons were treated with sEVs purified from primary cortical neurons or primary astrocytes. (<b>B</b>–<b>K</b>) Cortical neurons were treated with various concentrations (0.05–10 μg/mL) of sEVs purified from cortical neurons (<b>B</b>,<b>C</b>), astrocytes (<b>D</b>,<b>E</b>), LPS-activated astrocytes (<b>F</b>,<b>G</b>), 3D-astrocytes grown in collagen gel (<b>H</b>,<b>I</b>), and LPS-activated 3D-astrocytes (<b>J</b>,<b>K</b>) 4 h after plating. Neurons were fixed at 24 and 33 h, and neuronal morphology was examined in Tuj1 stained neurons. Representative images (<b>B</b>,<b>D</b>,<b>F</b>,<b>H</b>,<b>J</b>) and quantifications (<b>C</b>,<b>E</b>,<b>G</b>,<b>I</b>,<b>K</b>) are shown. Arrowheads mark the longest neurite. Scale bar, 40 μm. Neurite lengths are quantified from a minimum of 90 neurons per condition from 3 independent experiments and plotted as a violin plot, with values from each experiment distinctly colored and the median marked by a black line. Statistical significance: * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001 using one-way ANOVA with Dunnett’s post-test.</p>
Full article ">Figure 8
<p>A model depicting the effect of sEVs in promoting axon outgrowth and polarized neuronal morphology through Wnt-PCP signaling. sEVs secreted by L cells engage Wnt-PCP signaling in neurons to promote axon outgrowth that results in the acquisition of a polarized neuronal morphology. sEVs induce a shift in Vangl2 localization towards the distal axon. sEVs can be internalized by neurons and can colocalize with Wnt7b to promote the growth of the prospective axon. In contrast to fibroblast-derived sEVs, those isolated from activated astrocytes inhibit neurite outgrowth.</p>
Full article ">
22 pages, 4620 KiB  
Article
Potential of Cissampelos pareira L. Pectin as a Bioactive Compound in Moisturizing and Anti-Aging Applications
by Setinee Chanpirom, Nuntawat Khat-udomkiri, Thapakorn Tree-Udom, Naphatsorn Ditthawutthikul, Nisakorn Saewan, Maria Pilar Vinardell and Tawanun Sripisut
Cosmetics 2025, 12(1), 5; https://doi.org/10.3390/cosmetics12010005 - 3 Jan 2025
Viewed by 888
Abstract
Cissampelos pareira is a plant known for its edible and medicinal properties, with bioactive potential in various applications. This study aimed to isolate and characterize pectin from C. pareira (PCP) and assess its safety, as well as its efficacy in skin moisturizing and [...] Read more.
Cissampelos pareira is a plant known for its edible and medicinal properties, with bioactive potential in various applications. This study aimed to isolate and characterize pectin from C. pareira (PCP) and assess its safety, as well as its efficacy in skin moisturizing and anti-aging effects on human volunteers. The highest yield of PCP extraction was achieved after a 45 min extraction period. Chemical composition analysis using Fourier transform infrared (FT-IR) spectroscopy confirmed the presence of a characteristic pectin structure. Optimized PCP samples revealed high methoxy pectin content, degree of esterification, and galacturonic acid concentration, along with consistent physicochemical properties. PCP exhibited antioxidant activity and showed no cytotoxicity at 1 mg/mL, and effectively reduced hydrogen peroxide-induced oxidative damage in NIH/3T3 cells. Stability assessment indicated that PCP maintains its physical appearance and total polysaccharide content after heating–cooling periods. None of the PCP formulations caused skin irritation among volunteers. In an 8-week clinical trial, subjects who used serum formulations containing 0.5% w/w and 1.0% w/w PCP showed significant improvements in skin hydration and elasticity compared to the placebo serum group. While skin smoothness, scaliness, and wrinkling also improved, these anti-aging results were not statistically significant. The results indicated PCP is a promising candidate for skin care applications due to its safety, stability, antioxidant activity, and demonstrated efficacy in enhancing skin hydration and elasticity. Full article
Show Figures

Figure 1

Figure 1
<p><span class="html-italic">C</span>. <span class="html-italic">pareira</span>.</p>
Full article ">Figure 2
<p>The extracted PCP solution after refrigerating for 24 h (<b>a</b>), the filtered and washed PCP (<b>b</b>), and the dried PCP (<b>c</b>).</p>
Full article ">Figure 3
<p>The percentage yield of the PCP extracted using 95% ethanol as extraction solvent, under each condition at 15, 30, and 45 min. * indicates a significant difference (<span class="html-italic">p</span> &lt; 0.05) from the percentage yield of PCP. Data are represented as the mean ± S.D. from triplicate measurements.</p>
Full article ">Figure 4
<p>Fourier transform infrared spectra of PCP under each condition at 15, 30, and 45 min, and the apple pectin standard.</p>
Full article ">Figure 5
<p>Cytotoxicity of ascorbic acid (AA) and PCP in different concentrations. * indicates the significant difference from the control by LSD test (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 6
<p>Cellular antioxidant activity of ascorbic acid (AA) and PCP. * indicates the significant difference from the control by LSD test (<span class="html-italic">p</span> &lt; 0.05). # indicates the significant difference from the H<sub>2</sub>O<sub>2</sub> by LSD test (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 7
<p>Percentage change in skin hydration as measured by the Corneometer<sup>®</sup> (<b>a</b>) and in TEWL as measured by the Tewameter<sup>®</sup> (<b>b</b>). Values are given as mean ± SEM from triplicate measurements. * indicates the significant difference between FB and each formulation in the same week (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 8
<p>(<b>a</b>) Percentage change in skin elasticity (R2) as measured by the Cutometer<sup>®</sup>. Values are given as mean ± SEM from triplicate measurements. (<b>b</b>) Percentage change in skin elasticity (R5) as measured by the Cutometer<sup>®</sup>. Values are given as mean ± SEM from triplicate measurements. (<b>c</b>) Percentage change in skin firmness (R7) as measured by the Cutometer<sup>®</sup>. Values are given as mean ± SEM from triplicate measurements. * indicates the significant difference between each formulation in the same week (<span class="html-italic">p</span>-value &lt; 0.05).</p>
Full article ">Figure 8 Cont.
<p>(<b>a</b>) Percentage change in skin elasticity (R2) as measured by the Cutometer<sup>®</sup>. Values are given as mean ± SEM from triplicate measurements. (<b>b</b>) Percentage change in skin elasticity (R5) as measured by the Cutometer<sup>®</sup>. Values are given as mean ± SEM from triplicate measurements. (<b>c</b>) Percentage change in skin firmness (R7) as measured by the Cutometer<sup>®</sup>. Values are given as mean ± SEM from triplicate measurements. * indicates the significant difference between each formulation in the same week (<span class="html-italic">p</span>-value &lt; 0.05).</p>
Full article ">Figure 9
<p>Percentage change in skin smoothness (SEsm), measured by Visioscan<sup>®</sup>. Values are given as mean ± SEM from triplicate measurements.</p>
Full article ">Figure 10
<p>Percentage change in skin scaliness (SEsc), measured by Visioscan<sup>®</sup>. Values are given as mean ± SEM from triplicate measurements.</p>
Full article ">Figure 11
<p>Percentage change in skin wrinkling (SEw), measured by Visioscan<sup>®</sup>. Values are given as mean ± SEM from triplicate measurements.</p>
Full article ">
16 pages, 1000 KiB  
Article
Improving GPs’ Emotional Intelligence and Resilience to Better Manage Chronic Respiratory Diseases Through an Experiential Online Training Intervention: A Mixed Methods Study
by Katerina Boulougari, Antonios Christodoulakis, Izolde Bouloukaki, Evangelos C. Karademas, Christos Lionis and Ioanna Tsiligianni
Healthcare 2025, 13(1), 21; https://doi.org/10.3390/healthcare13010021 - 25 Dec 2024
Viewed by 493
Abstract
Background/Objectives: High levels of emotional intelligence (EI) and resilience in primary care physicians (PCPs) can help them communicate better with patients, build stronger relationships with colleagues, and foster a positive and collaborative workplace. However, studies have indicated that primary care physicians (PCPs) often [...] Read more.
Background/Objectives: High levels of emotional intelligence (EI) and resilience in primary care physicians (PCPs) can help them communicate better with patients, build stronger relationships with colleagues, and foster a positive and collaborative workplace. However, studies have indicated that primary care physicians (PCPs) often do not focus enough on developing these skills. Consequently, the purpose of this mixed methods study was to evaluate the effectiveness of an experiential online training (EOT) intervention in enhancing the EI and resilience of PCPs who treat patients with chronic respiratory diseases (CRDs). Methods: A total of 46 PCPs from Greece participated in a 25-hour EOT program, which focused on counseling skills for lifestyle change and breathing techniques for self-regulation. Quantitative data were collected using the Trait Emotional Intelligence Questionnaire-Short Form (TEIQue-SF) and the Connor–Davidson Resilience Scale (CD-RISC-25) before, immediately after, and three months post-intervention. Additionally, qualitative data were obtained through written reflections from participants regarding their clinical practice. Results: The results revealed significant improvements in EI and resilience scores immediately after the intervention (ΕΙ: 5.13, SD: 0.65 vs. 5.3, SD: 0.57, p = 0.007; resilience: 76.6, SD: 11.75 vs. 79.83, SD: 10.24, p = 0.029), as well as at the three-month follow-up (ΕΙ: 5.3, SD: 0.57 vs. 5.36, SD: 0.48, p = 0.007; resilience: 79.83, SD: 10.24 vs. 81.03, SD: 7.86, p = 0.029). The thematic analysis of qualitative data identified improvements in five key themes: communication skills, stress management, emotional awareness, resilience, and patient care. Participants reported feeling more confident, empathetic, and effective when interacting with patients, particularly those from diverse backgrounds. The convergence of the quantitative and qualitative findings showed the efficacy of the EOT intervention in enhancing PCPs’ EI, resilience, well-being, and, ultimately, their practice. Full article
(This article belongs to the Special Issue Improving Primary Care through Healthcare Education)
Show Figures

Figure 1

Figure 1
<p>The changes in the emotional intelligence levels of participants pre-intervention, post-intervention, and three months post-intervention.</p>
Full article ">Figure 2
<p>The changes in the resilience levels of participants pre-intervention, post-intervention, and three months post-intervention.</p>
Full article ">Figure 3
<p>Triangulation of quantitative and qualitative data.</p>
Full article ">
13 pages, 952 KiB  
Article
Postural Abnormalities in Children with Congenital Zika Syndrome-Related Neurological and Visual Impairment
by Raíne Borba, Amanda Rodrigues, Camila V. Ventura, Cláudia Marques, Lucélia Nóbrega, Taciana Higino, Dalmir Santos, Juliana Sallum and Liana O. Ventura
Viruses 2024, 16(12), 1959; https://doi.org/10.3390/v16121959 - 20 Dec 2024
Viewed by 617
Abstract
Deformities, body asymmetries, and muscle contractures are common consequences of atypical postural patterns in children with c ongenital Zika syndrome (CZS). This study aimed to evaluate the posture of children with CZS, considering their neurological and visual impairments. Ophthalmological assessment included binocular best-corrected [...] Read more.
Deformities, body asymmetries, and muscle contractures are common consequences of atypical postural patterns in children with c ongenital Zika syndrome (CZS). This study aimed to evaluate the posture of children with CZS, considering their neurological and visual impairments. Ophthalmological assessment included binocular best-corrected visual acuity (BCVA) using Teller Acuity Cards II (TAC II) and an ocular motility evaluation. Postural alignment was measured using the PhysioCode Posture (PCP) app. Twenty-four children with CZS (12 [50.0%] female) were included, with a mean age of 6.8 ± 0.7 years (range, 4.0–7.0 years). The majority (79.2% [19/24]) had microcephaly at birth. Visual impairment was detected in 95.2% (20/21) of the children, with 85.0% (17/20) classified as moderate, severe, or blind. Shoulder asymmetry was observed in 95.8% (23/24) of participants, and 75.0% (18/24) presented abnormal postural alignment of the head and hips. Additionally, spinal deviations were found in 41.7% (10/24) of the children. All children with CZS exhibited asymmetries and improper postural patterns, which may result from a combination of neurological and visual impairments as well as environmental factors. Full article
(This article belongs to the Special Issue Mosquito-Borne Encephalitis Viruses)
Show Figures

Figure 1

Figure 1
<p>(<b>a</b>)—Anterior views of the first child with congenital Zika syndrome within a lying position. Marking of points for the evaluation of the head (earlobes), shoulder (acromion), elbows (epicondyle), wrists (radius bone), hip (iliac crests), knees (patella), ankle (malleolus). (<b>b</b>)—Posterior views of the first child within a lying position. Marking of points for the evaluation of the spine (C7 and T12 vertebrae) and knees (popliteal line) and ankles.</p>
Full article ">Figure 2
<p>(<b>a</b>)—Anterior views of the second child with congenital Zika syndrome within a lying position. Marking of points for the evaluation of the head (earlobes), shoulder (acromion), elbows (epicondyle), wrists (radius bone), hip (iliac crests), knees (patella), ankle (malleolus). (<b>b</b>)—Posterior views of the first child within a lying position. Marking of points for the evaluation of the spine (C7 and T12 vertebrae) and knees (popliteal line) and ankles.</p>
Full article ">
18 pages, 1549 KiB  
Review
Breaking Left–Right Symmetry by the Interplay of Planar Cell Polarity, Calcium Signaling and Cilia
by De-Li Shi
Cells 2024, 13(24), 2116; https://doi.org/10.3390/cells13242116 - 20 Dec 2024
Viewed by 685
Abstract
The formation of the embryonic left–right axis is a fundamental process in animals, which subsequently conditions both the shape and the correct positioning of internal organs. During vertebrate early development, a transient structure, known as the left–right organizer, breaks the bilateral symmetry in [...] Read more.
The formation of the embryonic left–right axis is a fundamental process in animals, which subsequently conditions both the shape and the correct positioning of internal organs. During vertebrate early development, a transient structure, known as the left–right organizer, breaks the bilateral symmetry in a manner that is critically dependent on the activity of motile and immotile cilia or asymmetric cell migration. Extensive studies have partially elucidated the molecular pathways that initiate left–right asymmetric patterning and morphogenesis. Wnt/planar cell polarity signaling plays an important role in the biased orientation and rotational motion of motile cilia. The leftward fluid flow generated in the cavity of the left–right organizer is sensed by immotile cilia through complex mechanisms to trigger left-sided calcium signaling and lateralized gene expression pattern. Disrupted asymmetric positioning or impaired structure and function of cilia leads to randomized left–right axis determination, which is closely linked to laterality defects, particularly congenital heart disease. Despite of the formidable progress made in deciphering the critical contribution of cilia to establishing the left–right asymmetry, a strong challenge remains to understand how cilia generate and sense fluid flow to differentially activate gene expression across the left–right axis. This review analyzes mechanisms underlying the asymmetric morphogenesis and function of the left–right organizer in left–right axis formation. It also aims to identify important questions that are open for future investigations. Full article
Show Figures

Figure 1

Figure 1
<p>The Wnt/PCP pathway. (<b>A</b>) Non-canonical Wnt ligands bind to receptor and co-receptor complexes formed by Frizzled with Ror1/2 or with Ryk to activate downstream effectors via Dvl, regulating cytoskeletal rearrangements or transcriptional responses. The Scrib/Dlg/Lgl complex can regulate Vangl asymmetric localization. (<b>B</b>) Cell polarity is established by the interaction between two “core” PCP protein complexes that are distributed on opposite cell borders. Vangl and Prickle localize to the anterior side, while Frizzled, Dvl, and Ankrd6 are distributed at the posterior side. Celsr is present on both sides of the cell to propagate polarity information. DIX, DIX domain; PDB, PDZ domain-binding. (<b>C</b>) The Fat/Dchs polarity module. Fat and Dchs protocadherins form heterodimers between adjacent cells and function as a ligand–receptor pair. Phosphorylation of Fat by the Four-jointed (Fj) kinase enhances its binding with Dchs, but phosphorylation of Dchs by Fj reduces its interaction with Fat. Dachs is an unconventional myosin that interacts with Dchs and functions as a key effector of Fat/Dchs signaling.</p>
Full article ">Figure 2
<p>The L–R organizers in vertebrates. The zebrafish Kupffer’s vesicle, <span class="html-italic">Xenopus</span> posterior roof plate, chick Hensen’s node and mouse node are L–R organizers that function to establish the L–R asymmetry. By cilia-driven Nodal flow that triggers an increased calcium concentration on the left side (zebrafish, <span class="html-italic">Xenopus</span> and mouse) or by asymmetric cell migration (chick), the organizers activate differential gene expression across the L–R axis. As an outcome of calcium signaling, the reduced activity of Nodal signaling antagonists (Charon, Coco, and Dand5) leads to an increased expression of Nodal pathway genes on the left side of the lateral plate mesoderm. Upward pointing arrows indicate an increase of concentration or expression; downward arrows indicate a decreased expression.</p>
Full article ">Figure 3
<p>Organization and signaling of the mouse L–R organizer. Located at the posterior end of the notochord, the mouse node consists of pit cells (blue) at the central depression and crown cells (orange) at the periphery. The clockwise (ventral view) rotational movements of posteriorly tilted motile cilia on pit cells generates Nodal flow and causes an increased calcium concentration on the left side. Primary cilia on crown cells sense Nodal flow to activate calcium signaling, which represses the left-sided expression of Dand5 through a post-transcriptional mechanism. Polycystin 1 (PC1) and Polycystin 2 (PC2) are enriched in immotile cilia. They may form a heteromeric ion channel complex to mediate flow-induced activation or repression of gene expression by functioning as a mechanosensor and/or chemosensor.</p>
Full article ">Figure 4
<p>Brief summary of the temporal process leading to the determination of the L–R asymmetry. Further studies for elucidating the underlying mechanisms of ciliary functions are highlighted in red. The list of genes involved in the chain of events are not exhaustive. PC, Polycystin; AC, adenylyl cyclase; CaMKII, Ca<sup>2+</sup>/calmodulin-dependent protein kinase II; Inv, Inversion.</p>
Full article ">
16 pages, 2104 KiB  
Article
A New Three-Hit Mouse Model of Neurodevelopmental Disorder with Cognitive Impairments and Persistent Sociability Deficits
by Imane Mouffok, Caroline Lahogue, Thomas Cailly, Thomas Freret, Valentine Bouet and Michel Boulouard
Brain Sci. 2024, 14(12), 1281; https://doi.org/10.3390/brainsci14121281 - 20 Dec 2024
Viewed by 774
Abstract
Background/Objectives: Cognitive deficits and negative symptoms associated with schizophrenia are poorly managed by current antipsychotics. In order to develop effective treatments, refining animal models of neurodevelopmental disorders is essential. Methods: To address their multifactorial etiology, we developed a new three-hit mouse model based [...] Read more.
Background/Objectives: Cognitive deficits and negative symptoms associated with schizophrenia are poorly managed by current antipsychotics. In order to develop effective treatments, refining animal models of neurodevelopmental disorders is essential. Methods: To address their multifactorial etiology, we developed a new three-hit mouse model based on the hypoglutamatergic hypothesis of the pathology combined with early stress, offering strong construct validity. Thus, a genetic susceptibility (serine racemase deletion) was associated with an early environmental stress (24 h maternal separation at 9 days of age) and a further pharmacological treatment with phencyclidine (PCP, a glutamate receptor antagonist treatment, 10 mg/kg/day, from 8 to 10 weeks of age). The face validity of this model was assessed in female mice 1 and 6 weeks after the end of PCP treatment by a set of behavioral experiments investigating positive- and negative-like symptoms and cognitive deficits. Results: Our results showed that the three-hit mice displayed persistent hyperlocomotion (positive-like symptoms) and social behavior impairment deficits (negative-like symptoms) but non-persistent spatial working memory deficits (cognitive symptoms). Conclusions: Our work confirms the usefulness of a three-hit combination to model, particularly for negative-like symptoms associated with schizophrenia and other psychiatric disorders. The model therefore gathers powerful construct and face validities and supports an involvement of glutamate dysfunction in behavioral symptoms. Full article
(This article belongs to the Special Issue Exploring Negative Symptoms of Schizophrenia: Where Do We Stand?)
Show Figures

Figure 1

Figure 1
<p>Animal groups and experimental design. Behavioral assessment was conducted 1 and 6 weeks after the end of PCP/saline treatment using a set of behavioral experiments investigating positive- and negative-like symptoms and cognitive deficits. PCP: phencyclidine; MS: maternal separation; SRKO: serine racemase knock-out; s.c: subcutaneous; W: week.</p>
Full article ">Figure 2
<p>Spontaneous locomotor activity and anxiety-like behavior in the open field test during sessions 1 and 2 of the control (n = 10), 1-hit (PCP, n = 10), 2-hit (MS PCP, n = 10; SRKO PCP, n = 8), and 3-hit (SRKO MS PCP, n = 8) groups. Distance traveled (cm) in the open field arena during 10 min ((<b>A</b>,<b>D</b>) for sessions 1 and 2, respectively). Velocity (cm/s) in the open field arena ((<b>B</b>,<b>E</b>), for sessions 1 and 2, respectively). Total time (s) spent in the center of the open field ((<b>C</b>,<b>F</b>) for sessions 1 and 2, respectively). Data are presented as mean ± SEM. Grey dots represent individual data. Intergroup comparisons were performed using one-way ANOVA followed by Dunett’s multiple comparison test; * compared to control: * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01; *** <span class="html-italic">p</span> &lt; 0.001. PCP: phencyclidine; MS: maternal separation; SRKO: serine racemase knock-out; 3-hit: SRKO MS PCP.</p>
Full article ">Figure 3
<p>Spontaneous alternation in Y-maze test of controls (n = 10) and the 1-hit (PCP, n = 10), 2-hit (MS PCP n = 10; SRKO PCP, n = 8), and 3-hit (SRKO SM PCP, n = 8) groups. Distance traveled in the Y-maze for 5 min during session 1 (<b>A</b>) and 2 (<b>D</b>). Numbers of entries into the different arms during sessions 1 (<b>B</b>) and 2 (<b>E</b>). Spontaneous alternation percentage during sessions 1 (<b>C</b>) and 2 (<b>F</b>), with the dashed line represents 50% (i.e. chance level). Data are presented as mean ± SEM or as median ± interquartile. Grey dots represent individual data. Intergroup comparisons were performed using one-way ANOVA or the Kruskal–Wallis test followed by, respectively, Dunett’s or Dunn’s multiple comparison test; * compared to control: ** <span class="html-italic">p</span> &lt; 0.01; **** <span class="html-italic">p</span> &lt; 0.0001. # One-sample <span class="html-italic">t</span>-test Comparison to the reference value (50%) #: <span class="html-italic">p</span> &lt; 0.05; ##: <span class="html-italic">p</span> &lt; 0.01; ###: <span class="html-italic">p</span> &lt; 0.001; #### <span class="html-italic">p</span> &lt; 0.0001. PCP: phencyclidine; MS: maternal separation; SRKO: serine racemase knock-out; 3-hit: SRKO MS PCP.</p>
Full article ">Figure 4
<p>Social behavior of control (n = 10), 1-hit (PCP, n = 10), 2-hit (MS PCP, n = 10; SRKO PCP, n = 8), and 3-hit (SRKO SM PCP, n = 8) female mice. Distance traveled in the three-chamber apparatus for 10 min during session 1 (<b>A</b>) and 2 (<b>C</b>). Interaction time during sessions 1 (<b>B</b>) and 2 (<b>D</b>). Data are presented as mean ± SEM. Grey dots represent individual data. Intergroup comparisons were performed using two-way ANOVA with permutation followed by Sidak’s multiple comparison test. * E: empty vs. S: stimulus. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001, and **** <span class="html-italic">p</span> &lt; 0.0001. PCP: phencyclidine; MS: maternal separation; SRKO: serine racemase knock-out; 3-hit: SRKO MS PCP.</p>
Full article ">Figure 5
<p>Behavioral assessment summary. Comparison of behavioral performances between each experimental group and control group. ↗ indicates a significant increase compared to control; ↘ indicates a significant reduction compared to control; and = indicates no significant difference compared to control. PCP: phencyclidine; MS: maternal separation; SRKO: serine racemase knock-out; 3-hit: SRKO MS PCP.</p>
Full article ">
13 pages, 616 KiB  
Article
Perceptions and Experiences of Primary Care Providers on Their Role in Tobacco Treatment Delivery Based on Their Smoking Status: A Qualitative Study
by Stavros Stafylidis, Sophia Papadakis, Dimitris Papamichail, Christos Lionis and Emmanouil Smyrnakis
Healthcare 2024, 12(24), 2500; https://doi.org/10.3390/healthcare12242500 - 11 Dec 2024
Viewed by 627
Abstract
Introduction: Despite the well-documented benefits of smoking cessation interventions, the implementation and success of these programs in primary care settings often encounter significant barriers. A primary care provider’s personal smoking status has been identified as a potential barrier to tobacco treatment delivery. The [...] Read more.
Introduction: Despite the well-documented benefits of smoking cessation interventions, the implementation and success of these programs in primary care settings often encounter significant barriers. A primary care provider’s personal smoking status has been identified as a potential barrier to tobacco treatment delivery. The aim of this qualitative study is to explore the experiences and perspectives of primary care providers regarding their role in delivering smoking cessation interventions to patients based on their personal smoking status. Specifically, the study seeks to examine providers’ thoughts, emotions, and behaviors concerning their own smoking behavior and to understand their attitudes and actions when supporting patients who smoke and to explore their perspectives on the effectiveness of training programs designed to promote tobacco treatment. Materials and Methods: Semi-structured interviews were conducted with 22 primary care providers from six public primary care units in the Central Macedonia Region, Greece. Thematic analysis was used to analyze data. Results: Healthcare providers who are current smokers may face unique challenges in effectively counseling patients on smoking cessation. On the contrast, non-smoking and especially previous smoking healthcare providers were noted to exhibit greater confidence and efficacy in delivering cessation support, often serving as role models for patients aiming to quit smoking. Participating in structured cessation training programs often led healthcare professionals to reflect and reevaluate their own smoking behaviors. Conclusions: Personal smoking status of primary care providers impacts the delivery of tobacco treatment, affecting their credibility and effectiveness in providing cessation support. Educational programs positively impact attitudes and behaviors, underscoring their importance in improving both PCPs’ professional effectiveness and personal health outcomes. These findings suggest that addressing PCPs’ smoking habits and enhancing training opportunities are critical for optimizing smoking cessation services. Full article
Show Figures

Figure 1

Figure 1
<p>Thematic map of PCPs’ attitudes on personal smoking, their role in smoking cessation and their views on smoking cessation educational programs.</p>
Full article ">
15 pages, 2792 KiB  
Article
Evidence for the Transcription of a Satellite DNA Widely Found in Frogs
by Jennifer Nunes Pompeo, Kaleb Pretto Gatto, Diego Baldo and Luciana Bolsoni Lourenço
Genes 2024, 15(12), 1572; https://doi.org/10.3390/genes15121572 - 5 Dec 2024
Viewed by 816
Abstract
Background: The satellite DNA (satDNA) PcP190 has been identified in multiple frog species from seven phylogenetically distant families within Hyloidea, indicating its broad distribution. This satDNA consists of repeats of approximately 190 bp and exhibits a highly conserved region (CR) of 120 bp, [...] Read more.
Background: The satellite DNA (satDNA) PcP190 has been identified in multiple frog species from seven phylogenetically distant families within Hyloidea, indicating its broad distribution. This satDNA consists of repeats of approximately 190 bp and exhibits a highly conserved region (CR) of 120 bp, which is similar to the transcribed region of 5S ribosomal DNA (rDNA), and a hypervariable region (HR) that varies in size and nucleotide composition among and within species. Here, to improve our understanding of PcP190 satDNA, we searched for evidence of its transcription in the available transcriptomes of Rhinella marina (Bufonidae) and Engystomops pustulosus (Leptodactylidae), two phylogenetically distantly related species. Methods: We first characterized the 5S rDNA and PcP190 sequences in these species by searching for them in available genome assemblies. Next, we used the PcP190 (CR and HR) and 5S rDNA sequences of each species as queries to search for these sequences in RNA-seq libraries. Results: We identified two types of 5S rDNA in each analyzed species, with a new type found in E. pustulosus. Our results also revealed a novel type of PcP190 sequence in R. marina and a new subtype of PcP-1 in E. pustulosus. Transcriptome analyses confirmed the expected transcription of the 5S rRNA gene and showed transcription of both the CR and HR of the PcP190 satDNA in both species and in different tissues. Conclusions: As the entire repeat of this satDNA is susceptible to transcription, the high variability observed in the HR cannot be attributed to transcriptional activity confined to the CR. Full article
(This article belongs to the Section Animal Genetics and Genomics)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Maximum likelihood analysis of the transcribed region of all types of 5S rDNA found in the subfamily Leiuperinae. Note that the sequences from <span class="html-italic">E. pustulosus</span> (highlighted in purple and dark blue) are clustered into two distinct groups, namely type II and type III 5s rDNA.</p>
Full article ">Figure 2
<p>Maximum likelihood analysis of the HR of all type I PcP190 sequences. The branches corresponding to the PcP-1a sequences are shown in light green. The PcP-1a sequence of <span class="html-italic">E. pustulosus</span> is highlighted in gray.</p>
Full article ">Figure 3
<p>Alignment of the sequences referring to the nine haplotypes representing the PcP190 satDNA found in <span class="html-italic">R. marina</span>.</p>
Full article ">Figure 4
<p>Maximum likelihood analysis of the 5S rDNA transcribing region and CR regions of the PcP190 satDNA of anurans.</p>
Full article ">Figure 5
<p>Evidence of the transcription of satDNA PcP-1c in <span class="html-italic">E. pustulosus</span>. (<b>A</b>) Mapping of reads from two RNA-seq libraries from <span class="html-italic">E. pustulosus</span> eyes to the sequence of satDNA PcP-1c from the same species. Note that both the CR (brown bar) and the HR (light green bar) were mapped. (<b>B</b>) FPKM values calculated for each library. The accession number of each RNA-seq library is below its respective bar.</p>
Full article ">Figure 6
<p>Evidence of the transcription of satDNA PcP190 in <span class="html-italic">R. marina</span>. (<b>A</b>) Mapping of reads from ovaries (<b>left</b>) and testis (<b>right</b>) RNA-seq libraries from <span class="html-italic">R. marina</span> to a PcP190 sequence from the same species. Note that both the CR (light pink bar) and the HR (dark pink bar) were mapped. (<b>B</b>) FPKM values calculated for each library. The accession number of each RNA-seq library is below its respective bar.</p>
Full article ">
8 pages, 194 KiB  
Article
Participation in Tobacco Cessation Programs Among Medicaid Managed Care Enrollees in Florida
by Rahma S. Mkuu, Casey C. Glymph, Peyton A. Lurk, Madison R. McCraney, Jennifer H. LeLaurin, Ramzi G. Salloum, Jaclyn M. Hall and Christopher R. Cogle
Healthcare 2024, 12(22), 2319; https://doi.org/10.3390/healthcare12222319 - 20 Nov 2024
Viewed by 841
Abstract
Background/Objectives: Tobacco use remains a significant public health issue, particularly among individuals with low incomes, including Medicaid recipients who often face multiple barriers to quitting. This study aimed to identify barriers, from the perspective of Medicaid managed care organizations (MCOs), influencing Medicaid [...] Read more.
Background/Objectives: Tobacco use remains a significant public health issue, particularly among individuals with low incomes, including Medicaid recipients who often face multiple barriers to quitting. This study aimed to identify barriers, from the perspective of Medicaid managed care organizations (MCOs), influencing Medicaid recipient participation in tobacco cessation programs. Methods: Focus group interviews were conducted with Florida Medicaid MCOs to elicit processes for case identification, outreach, referral, program participation, and incentives. Answers were synthesized into themes. Results: Medicaid recipients were primarily identified through nicotine dependency claim codes or Health Risk Assessments (HRAs). Individuals were referred to state and local community tobacco cessation programs through text messaging and outreach by MCO case managers. The MCOs identified the following as barriers: primary care physicians (PCPs) with limited knowledge about cessation programs and pharmacologic treatments for nicotine dependence, low availability of health coaches, long wait times for entry into cessation programs, weak coordination between MCOs and cessation programs, and insufficient incentives for individuals for program participation. Suggested strategies to overcome barriers were continuing medical education (CME) for PCPs about tobacco cessation programs and prescription therapies, increasing the training of health coaches, more investment in quitlines, increasing data sharing between MCOs and cessation programs, and increasing incentives for individuals. Conclusions: These findings highlight the importance of engaging MCOs in discussions about policy and program improvements, as their insights can drive meaningful changes in how tobacco cessation and other preventive health programs are structured and implemented. Targeted interventions are needed to enhance tobacco cessation program participation among Medicaid recipients. Full article
(This article belongs to the Special Issue Medicaid and Public Health: Second Edition)
3 pages, 144 KiB  
Commentary
American College of Medical Genetics and Genomics ACT Sheets Are a Vital Resource for State Newborn Screening Programs
by Virginia Sack, Sara Etienne, Grace Beal, Sarah Bradley and Michele Caggana
Int. J. Neonatal Screen. 2024, 10(4), 75; https://doi.org/10.3390/ijns10040075 - 19 Nov 2024
Viewed by 978
Abstract
The American College of Medical Genetics and Genomics (ACMG) and the National Coordinating Center for the Regional Genetics Networks (NCC)-developed ACT sheets are a vital resource for state newborn screening (NBS) programs. They allow NBS programs to be able to provide up-to-date, just-in-time [...] Read more.
The American College of Medical Genetics and Genomics (ACMG) and the National Coordinating Center for the Regional Genetics Networks (NCC)-developed ACT sheets are a vital resource for state newborn screening (NBS) programs. They allow NBS programs to be able to provide up-to-date, just-in-time disorder information to primary care providers (PCPs). Their continued availability is necessary to ensure that all babies identified by newborn screening receive appropriate evaluation and care. Full article
20 pages, 7201 KiB  
Review
A Pathological Assessment of the Microvasculature of Biliary Tract Neoplasms Referring to Pre-Existing Blood Vessels and Vessel Co-Option
by Yasuni Nakanuma, Zihan Li, Yasunori Sato, Motoko Sasaki, Kenichi Harada, Yuko Kakuda and Takashi Sugino
Cancers 2024, 16(22), 3869; https://doi.org/10.3390/cancers16223869 - 19 Nov 2024
Cited by 1 | Viewed by 827
Abstract
There are several types of microvasculature supplying neoplasms: “newly formed blood vessels” (neoangiogenesis), which are a component of the tumor microenvironment (TME) of invasive carcinoma with wound healing-like reaction; and “pre-existing blood vessels”, which are used as tumor-supplying vessels by neoplasms (co-option vessels) [...] Read more.
There are several types of microvasculature supplying neoplasms: “newly formed blood vessels” (neoangiogenesis), which are a component of the tumor microenvironment (TME) of invasive carcinoma with wound healing-like reaction; and “pre-existing blood vessels”, which are used as tumor-supplying vessels by neoplasms (co-option vessels) and are likely to develop in hypervascularized organs. We herein review the microvasculature of neoplasms of biliary tract with reference to pre-existing vessels and vessel co-options. In the hepatobiliary system, intrahepatic large and extrahepatic bile ducts (large bile ducts) and the gallbladder as well as hepatic lobules are highly vascularized regions. In large bile ducts, the biliary lining epithelia and underlining capillaries (peribiliary capillary plexus [PCP]) form the biliary epithelia–PCP alignment, whereas the hepatocyte–sinusoid alignment composes hepatic lobules. Cholangiocarcinoma (CCA) and gallbladder carcinoma (GBC) are the main biliary tract carcinomas. CCA is subdivided into distal (d/CCA), perihilar (pCCA), and intrahepatic (iCCA), and iCCA is subdivided into small duct type (SD-iCCA) and large duct type (LD-iCCA). High-grade biliary intraepithelial neoplasm (BilIN), intraductal papillary neoplasm of the bile duct (IPNB), pyloric gland adenoma (PGA), and intracholecystic papillary neoplasm (ICPN) have recently been proposed as the precursors of LD-iCCA, p/dCCA, and GBC. In the large bile ducts and gallbladder, all cases of high-grade BilIN and PGA, about half of IPNB, and one-third of ICPN with less-complicated structure were found to have hijacked the PCP as their supporting vessels (vessel co-option), while p/dCCA, LD-iCCA, and GBC were supplied by neo-angiogenetic vessels associated with fibrous stroma. The intraluminal components of the remaining cases of ICPN and IPNB with complicated structure presented sparse capillaries without fibrous stroma, a unique microvasculature different from that of co-option or neoangiogenesis. Regarding iCCA showing invasion into the hepatic lobules, some SD-iCCAs replaced hepatocytic cords and used pre-existing sinusoids as co-opted vessels. Visualization of pre-existing vessels could be a new pathological tool for the evaluation of malignant progression and of vascular supply in CCAs and its precursors. Full article
(This article belongs to the Collection Treatment of Hepatocellular Carcinoma and Cholangiocarcinoma)
Show Figures

Figure 1

Figure 1
<p>Dotted capillaries are located just beneath of the lining biliary epithelia (peribiliary capillary plexus [PCP]) in non-neoplastic intrahepatic large bile duct. L, bile duct lumen. CD34 immunostaining.</p>
Full article ">Figure 2
<p>In the fibrous stroma of invasive gallbladder carcinoma, several vessels positive for CD34 are found. They are not oriented to carcinoma glands. (<b>A</b>), HE; and (<b>B</b>), CD34 immunostaining.</p>
Full article ">Figure 3
<p>Dotted chain-like capillaries resembling peribiliary capillary complex (PC) of normal bile ducts are located under neoplastic epithelia of high-grade biliary intraepithelial neoplasm (BilIN). (<b>A</b>), HE and (<b>B</b>), CD34 immunostaining.</p>
Full article ">Figure 4
<p>CD34-positive capillaries are regularly found in the fine stalks of papillary neoplasms. Intraductal papillary neoplasm of bile duct (IPNB) (type 1) of intestinal subtype. (<b>A</b>), HE; and (<b>B</b>), CD34 immunostaining.</p>
Full article ">Figure 5
<p>Capillaries are sparse in the intraluminal component, showing solid or cribriform growth (<b>right</b> to <b>center</b>), while regular and dotted capillaries are found in the stalks of papillary neoplasms in other areas (<b>left</b>) in the same case. Intraductal papillary neoplasm of bile duct (IPNB) (type 2) of intestinal subtype with foci of type 1 IPNB areas. (<b>A</b>), HE; and (<b>B</b>), CD34 immunostaining.</p>
Full article ">Figure 6
<p>Atypical glands (G) surrounded by C34-positive dotted capillaries are located near the non-neoplastic peribiliary glands (*) of the cancerous bile duct of extrahepatic cholangiocarcinoma. CD34 immunostaining.</p>
Full article ">Figure 7
<p>Hepatocytes (blue) arranged in cords are lined by sinusoidal cells (brown) forming hepatocyte–sinusoidal alignment. P, portal vein. Normal liver. Double immunostaining of HepParI (blue) and collagen type IV (brown).</p>
Full article ">Figure 8
<p>Carcinoma cells (brown) are in direct contact with non-neoplastic hepatocytes (hematoxylin-colored), presenting the replacement of hepatocytes by carcinoma cells. These carcinoma cells are surrounded by blue-colored sinusoidal cells (capillarized sinusoidal cells), suggesting vessel co-option. Sinusoidal cells that are not capillarized in the hepatic lobules are not stained with CD34. Replacement growth of cholangiocellular carcinoma. H, non-neoplastic hepatocyte. Hematoxylin and double immunostaining of CD34 (blue) and CK19 (brown).</p>
Full article ">
Back to TopTop